chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FEELING ACHY; SINUSES WERE CLOG; TIRED FROM NOT SLEEPING; COULDN'T GET WARM; NO SIDE EFFECTS; SHIVERING; HEADACHE; NAUSEOUS; FEVER; TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805028 expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced feeling achy, sinuses were clog, tired from not sleeping, couldn't get warm, shivering, headache, nauseous, fever,  tired and 48 hours after vaccination had no side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feeling achy, shivering, tired, couldn't get warm, fever, nauseous, sinuses were clog, headache, tired from not sleeping and no side effects was not reported. This report was non-serious.
This spontaneous report was received from a registered nurse refers to an approximately 8 month old patient. On 19-AUG-2013, the patient was vaccinated with oral ROTATEQ, (lot number, expiry date was unknown) dose 1. On 21-Oct-2013, the patient was vaccinated with oral ROTATEQ, (lot number, expiry date was unknown) dose 2. On 07-Mar-2014, the patient was vaccinated with oral ROTATEQ, (lot number, expiry date was unknown) dose 3. No adverse event reported was reported. Additional information is not expected.
Fever of 100.9, chills, muscle aches, headache, sore lymph nodes, and fatigue all started around 1am 3/11/21. Fever and chills stopped around 6am 3/11/21. Other symptoms continued until about 8am 3/12/21.
tenderness at injection site; This is a spontaneous report from a contactable other hcp (patient). The 57-years-old female patient (not pregnant) received first dose of bnt162b2 (BNT162B2, lot number: EK4176), on left arm unknown on 09Jan2021 13:30 at SINGLE DOSE for covid-19 immunisation.  Medical history was none. The patient did nor receive other vaccine in four weeks. The patient did not experience COVID prior the vaccination. The patient did not test covid post vaccination. No known allergies. Concomitant medication included alprazolam (XANAX), cetirizine hydrochloride (ZYRTEC DAIICHI), omeprazole (PRILOSEC), zolpidem tartrate (AMBIEN). The patient experienced tenderness at injection site on 10Jan2021 05:00, described as Woke up the next morning with tenderness at injection site. No swelling or redness. No treatment received for the event. The outcome of the event was recovering.  No follow-up attempts possible. No further information expected.
Fever 103.5, headache, all over body aches, chills, nausea
Patient got her shot at Pharmacy and within an hour, had tongue swelling, hives around the injection site, difficulty breathing, hallucinating.  Had her own EPipen and used it before going to the ER.  Went to ER (mother drove her) and she received antihistamines, steroids there.  Diagnosed with anaphylactic reaction to the Pfizer vaccine.  Went back to he ER the next day for continued tongue swelling after initial visit. Had 7 days of prednisone.  Seeing allergist (me) 10 days later and still has tongue swelling (mild), some BP increases that she typically doesn't have.
PAtient received 1st Pfizer BioNTech 0.2mL immunization. During 15 minute post vaccination waiting epriod. Patietn father called for help, states "i asked him a question, he answered, i looked away for a second and when i looked back he was passed out and not responding". This RN arrived to patient prior to regain of conciousness. patient unocnsious for approximately 30-45 seconds. when he woke up he states "i feel fine, i jsut feel like i went to sleep, but i feel hot." Patient given water, Ice pack, and a snack. Patient monitored for an additional 15 minutes after event occured. Patient left feeling normal. Father advised to seek medical attention for any further issues or cocnerns.
Patient sat down next to me on the couch around 4:00 PM Dec 7 (Tuesday). I was finishing work (I work in clinical drug development) and he sat back on the couch. His head went back onto the cushion and tilted to the right side. His eyes rolled into his head, he started mumbling incoherent words, and was unresponsive to me calling his name several times. The event lasted several seconds (maybe 5-6 seconds in total) at which he was unresponsive/lost consciousness. It seems that he either had a seizure or experienced some sort of syncope. He then came to, and had absolutely no recollection that any event had taken place. No realization at all. Had I not witnessed the event, neither one of us would have known that anything untoward had occurred. After the event he was extremely tired and slept for about an hour or so. He had a visit scheduled with his rheumatologist for December 9 (2 days post-event) where he mentioned this event. His Rheumatologist recommended that he report the event to VAERS as this seizure/syncope occurred within ~72 hours post-vaccination (3rd shot, booster, Pfizer COVID-19). Patient has had no other known events since that initial adverse event.
Numbness around the site of the vaccination lasting about an hour. No change in strength or other symptoms.
No additional adverse events reported; a dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported.   On 25-JAN-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (route not reported; lot #U020244, expiration date 28-JUN-2023) for prophylaxis (product storage error).   The administered dose of the vaccine experienced a temperature excursion in the range 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds, and in the range 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.
Had generally expected SE-- fatigue, arm soreness, redness at the injection site, but then developed slightly itchy rash with pinpoint erythematous papules on arms, wrist, knees in addition to rash on upper arm
Diarrhea (3 events same night), dizziness, general malaise (only A.M dizziness and malaise remains).
1-2 minutes after shots, patient stated that he didn't feel well.  He became diaphoretic in the face, pale, and stated he was nauseated.  He was able to walk over to the bed to lie down in shock position.  Pt. never lost consciousness.  Was alert and oriented x 3.  BP checks 88/62, 98/72, 110/78.  Respirations WNL.  Water offered for patient.  Able to sit up and drink the whole cup.  Patient sucking on a lollipop when left.  Stated he felt better.  No syncope.  Patient with nurse for 45 minutes.  Patient's father called and notified over the phone of the above.  Grandmother with patient the whole time.
Pt exp eyes rolled back & generalized tremor brief x 2, followed by nonstop abnormal crying x 3 hrs;
Pfizer on 1/22 and 2/12. Positive on 9/29
Fever during 36 hours starting 12 hours after the vaccine application. Fever was about 100 but reached 103 about 24 hours after the vaccine application.  Extreme fatigue for during the first 36 hours after vaccine application. And fatigue for 24 hours more.  Tension in left arm.  A bit of a rush close to the right wrist and the left elbow.  A bit of coughing.
headache; swollen lymph nodes; muscle/joint pain; joint pain; tiredness; injection site soreness; injection site swelling; nausea; generally felt unwell; This is a spontaneous report from a contactable Consumer (Patient). A 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 13Feb2021 16:00 (Batch/Lot Number: EM9809) as single dose for covid-19 immunisation. Medical history included arthritis and overweight from an unknown date and unknown if ongoing. Concomitant medication included meloxicam and zolpidem. On 15Feb2021 08:00, the patient experienced headache, swollen lymph nodes, muscle/joint pain, joint pain, tiredness, injection site soreness, injection site swelling, nausea and generally felt unwell. The action taken in response to the events for bnt162b2 was not applicable. The outcome of event was recovering.
No adverse events were noted or reported but vaccine was given 4 days after its beyond-use-date in the fridge
I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 ATRIAL FIBRILLATION, UNSPECIFIED I95.9 HYPOTENSION 12/10/2021 ATRIAL FIBRILLATION, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 ATRIAL FIBRILLATION, UNSPECIFIED R09.02 HYPOXIA 12/10/2021 ATRIAL FIBRILLATION, UNSPECIFIED I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 SYSTOLIC HEART FAILURE, UNSPECIFIED ACUITY I95.9 HYPOTENSION 12/10/2021 SYSTOLIC HEART FAILURE, UNSPECIFIED ACUITY J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 SYSTOLIC HEART FAILURE, UNSPECIFIED ACUITY R09.02 HYPOXIA 12/10/2021 SYSTOLIC HEART FAILURE, UNSPECIFIED ACUITY I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 MITRAL VALVE REGURGITATION I95.9 HYPOTENSION 12/10/2021 MITRAL VALVE REGURGITATION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 MITRAL VALVE REGURGITATION R09.02 HYPOXIA 12/10/2021 MITRAL VALVE REGURGITATION I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 MITRAL VALVE REGURGITATION I95.9 HYPOTENSION 12/10/2021 MITRAL VALVE REGURGITATION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 MITRAL VALVE REGURGITATION R09.02 HYPOXIA 12/10/2021 MITRAL VALVE REGURGITATION I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 12/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA R09.02 HYPOXIA 12/10/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 MITRAL VALVE REGURGITATION I95.9 HYPOTENSION 12/10/2021 MITRAL VALVE REGURGITATION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 MITRAL VALVE REGURGITATION R09.02 HYPOXIA 12/10/2021 MITRAL VALVE REGURGITATION I26.99 ACUTE PULMONARY EMBOLISM 10/22/2021 ALLERGIC RHINITIS I95.9 HYPOTENSION 12/10/2021 ALLERGIC RHINITIS J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/14/2021 ALLERGIC RHINITIS R09.02 HYPOXIA 12/10/2021 ALLERGIC RHINITIS
Sore arm within first day. By next evening coughing and complaining of shortness of breath when coughing. Around bed time, complained of thumb width pain around center of each breast and one at bottom of rib cage.  Daughter insisted on going to bed instead of emergency room showing whatever she was experiencing was mild. By morning coughing and shortness of breath were gone but she still had pain over heart and lower rib cage. Once again she insisted on going to school over the doctors.  By 3:30 pm the pain was gone.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and unknown gender. The patient's pertinent medical history was not reported. On an unknown date, the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX. No adverse effects were reported. Additional information has been requested.
Patient has not received the 3rd dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (received 1st dose on 01st June 2021) and Twinrix (received 2nd dose on 1st July 2021).   On an unknown date, the patient received Twinrix (injection) and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient was the reporter's wife. At the time of reporting, the patient wanted to know about the dosing schedule of Twinrix (if a 3rd dose was required), components in Twinrix and availability of the vaccine.  Till the time of reporting, the patient did not receive the 3rd dose of the vaccine, which led to incomplete course of vaccination.
About 10 minutes after receiving dose 1 of her Pfizer Covid-19 vaccine, Patient felt dizzy, nauseous, looked pale, and was diaphoretic.
Migraine, heart beat racing, resting heart rate 150, feel like I was in an accident, drooping face, slurred speech, confusion, insomnia, but feel like I need to sleep.
Pt recv vax on 10/21/98; 2 hr post vax pt exp difficulty swallowing, red/burning eyes, headache, joint pain; pt imp 24 hr
Information has been received from a health professional concerning a 7 year old female patient who was vaccinated on 10/27/1999 with a dose of varicella virus vaccine live (Oka/Merck).  Subsequently, on approximately 02/10/2004, the patient developed breakthrough chickenpox with less than 50 lesions.  Follow up information indicated that there was not a single report of adverse reaction following varicella vaccination.  The reporter indicated that 49 other patients developed breakthrough cases of chickenpox.  No additional information is expected.
Severe low back pain. Pain in right buttock. Gait unsteadiness. Pain is persistent three weeks after receiving shot, though less severe.
pt had vax in 11/9/95 & had wild varicella disease 6/99; moderate case
This spontaneous case reported by a nurse, describes the occurrence of tongue discoloration in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026L20A) for COVID-19 immunization. No medical history reported. On Jan 13, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 10, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 28, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced tongue discoloration. At the time of the report, tongue discoloration: not resolved. The action taken with mRNA-1273 (COVID-19 Moderna vaccine): not applicable. The reporter did not provide any causality assessments, concomitant medications or treatment information.
Dizziness, weak, headache, spacey, swollen lymph nodes, soreness on left side.  Fri PM - chills, headache.  Sat AM then got dizzy and passed out.
At night patient had a lot of itching in the vaccine administration area. In the morning, the arm was inflamed, red and with pain. She went to doctors office and prescribed antibiotics.
A report has been received from a Health Professional concerning a patient, Female subject, who had been receiving FLUMIST QUARDIVALENT (intranasal). FLUMIST QUARDIVALENT started on an unknown date. The patient received expired FLUMIST QUARDIVALENT. The outcome of the event of administered expired FLUMIST QUARDIVALENT is unknown. The report was considered to be non-serious.
Terrible pain in the arm; Cannot lift the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Terrible pain in the arm) and HYPOKINESIA (Cannot lift the arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Terrible pain in the arm) and HYPOKINESIA (Cannot lift the arm). At the time of the report, PAIN IN EXTREMITY (Terrible pain in the arm) and HYPOKINESIA (Cannot lift the arm) outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD21-071279 (E2B Linked Report). This case was linked to MOD-2021-069571 (Patient Link).; Sender's Comments:  MOD21-071279:Husband's Case.
Left upper thigh vaccine area red and sore. Redness approx. 5cm round area.
Sore throat, dizziness,chills,headache and stroke, severe chest pain and  weakness on right side. Went to the ER at Medical center. on. October 24, 2022 and was admitted. Diagnosed with having a stroke.
onset of chills and fever and fatigue and headache 6 hours following injection; improvement by next morning, although fatigue and slight headache remain
patient received pneumvax on 9/16/08 at 12:05 pm.she called arround 7 pm,and said that she was experiencing redness,and discomforin area of shot.she was told by the rph to ice are,and if worsens to see a phycisian.i called her at 9 am on 9/17/08. she saw her primary physician,and received a prescription for triamcinolon 0.1 % cream
Tireness; Body aches; Fever; Cough; This is a spontaneous report from a contactable consumer or other non health care professional. A patient 6th decade of unspecified gender received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number- Not reported) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. Medical history included breast cancer survival (Optional Information: Breast Cancer Survival) and Covid-19 from 2020 to an unknown date. The patient's concomitant medications were not reported. On an unspecified date patient experienced tireness, body aches, fever and cough. It was reported that event took place 24 hours after use of product. The outcome of all the events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
I had an appointment that was cancelled due to "no vaccine from the CDC".   VAMS ID: VAMS-106446464  Suspect possible fraud, and requesting investigation, or for the CDC to take note of  Pharmacy.
Chills and shaking after first dose; Extreme arm pain after first dose; Swelling at vaccine site after 1st dose; Chills and shaking after first dose; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (Chills and shaking after first dose), PAIN IN EXTREMITY (Extreme arm pain after first dose), VACCINATION SITE SWELLING (Swelling at vaccine site after 1st dose) and CHILLS (Chills and shaking after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TREMOR (Chills and shaking after first dose), PAIN IN EXTREMITY (Extreme arm pain after first dose), VACCINATION SITE SWELLING (Swelling at vaccine site after 1st dose) and CHILLS (Chills and shaking after first dose). At the time of the report, TREMOR (Chills and shaking after first dose), PAIN IN EXTREMITY (Extreme arm pain after first dose), VACCINATION SITE SWELLING (Swelling at vaccine site after 1st dose) and CHILLS (Chills and shaking after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported  No treatment information was provided   Reporter did not allow further contact
Pt received TIV in (L) deltoid, the following day reported numbness below the (R) knee & (R) foot pain.
Patient was hospitalized on 12/12/2021 for chest pain, hemoptysis and sinus tachycardia. Possible pulmonary embolism. Small right sided pleural effusion. Pleuritic chest pain. Palpitations. Other work up negative. Symptoms started day following vaccine.   She was symptomatic from sinus tachycardia but only with exertion.
Patient stated that he began to experience frozen shoulder from incorrect location of shot and proceeded to emergency room 2 hours after getting the shot.
Second dose of Pfizer was given 12 days after initial dose.  Vital signs normal. No adverse events after administration and 30 minute observation period.
This spontaneous report as received from a licensed practitioner refers to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VARIVAX, (lot#, strength, dose, frequency and route unspecified). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Shingrix administrated with wrong adjuvant; antigen was reconstituted with a steroid water intended for live virus vaccines versus the adjuvant that Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number 252jx, expiry date 14th September 2023) for prophylaxis.   On 10th July 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 10th July 2022, unknown after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.    Additional Information: GSK receipt date: 5-AUG-2022 Reporters comment: Patient received Shingrix vaccine and that was reconstituted with the wrong adjuvant in the left arm. The reporter reported that the antigen was reconstituted with a steroid water intended for live virus vaccines versus the adjuvant that Shingrix came with.  The reporter did not consent to follow-up.  No HCP for follow up. Additional Supportive information: Patient received Shingrix vaccine and that was reconstituted with the wrong adjuvant which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
Cold like symptoms - mild dry cough, loss of smell (for weeks), loss of taste (3 days), diarrhea, blurred vision, and tired.   Urgent care gave me antibiotics and cough medicine. Took antibiotics, but not the cough medicine. Also wanted me to take Vitamin C, Zinc, and Vitamin D. Zinc made me barf.  Did over the counter Nighttime cough medicine - worked fine.